DnA9V
DnA9V
DnA9V
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
242. Cancer care Ontario Practice Guidelines Initiative. Use of 5-HT 3<br />
receptor antagonists in patients<br />
receiving moderately or highly emetogenic chemotherapy. Disponible en: www cancercare<br />
on ca/ [accedido en: septiembre 2007]<br />
243. Critchley P, Plach N, Grantham M, Marshall D, Taniguchi A, Latimer E, et al. Efficacy of<br />
haloperidol in the treatment of nausea and vomiting in the palliative patient: A systematic<br />
review [3]. Journal of Pain & Symptom Management. 2001;22(2):631-4.<br />
244. Aapro MS, Molassiotis A, Olver I. Anticipatory nausea and vomiting. Support Care Cancer.<br />
2005;13(2):117-21.<br />
245. Ahmedzai SH, Boland j. Constipation in people prescribed opioids. In: BMJ Publishing Group,<br />
editor. Clinical Evidence. London: 2007. p. 2407.<br />
246. Miles CL, Fellowes D, Goodman ML, Wilkinson S. Laxatives for the management of constipation<br />
in palliative care patients. Cochrane Database Syst Rev. 2006;(4):CD003448.<br />
247. Sykes N. Constipation and diarrhoea. In: Doyle D, Hanks G, Chreney N, Calman K, editors.<br />
Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004. p.<br />
483-96.<br />
248. Benson AB, III, Ajani JA, Catalano RB, Engelking C, Kornblau SM, Martenson JA, Jr., et<br />
al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin<br />
Oncol. 2004;22(14):2918-26.<br />
249. Cascinu S, Bichisao E, Amadori D, Silingardi V, Giordani P, Sansoni E, et al. High-dose loperamide<br />
in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients.<br />
Supportive care in cancer : official journal of the Multinational Association of Supportive<br />
Care in Cancer. 2000;8:65-7.<br />
250. Geller RB, Gilmore CE, Dix SP, Lin LS, Topping DL, Davidson TG, et al. Randomized trial of<br />
loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone<br />
marrow transplant and leukemia patients. American journal of hematology. 1995;50:167-72.<br />
251. Pezzella G, Pisconti S. Octreotide versus loperamide in controlling chemotherapy-induced<br />
diarrhoea. Giornale Italiano di Oncologia. 1994;14:79-82.<br />
252. Cascinu S, Fedeli A, Fedeli SL, Catalano G. Octreotide versus loperamide in the treatment<br />
of fluorouracil-induced diarrhea: a randomized trial. Journal of clinical oncology : official<br />
journal of the American Society of Clinical Oncology. 1993;11:148-51.<br />
253. Sherman DM, Mangini L, Poirier P, Kadish SP. Double-blind comparison of loperamide and<br />
placebo in the treatment of radiation-induced diarrhea. ADV THER. 1989;6:103-11.<br />
254. Szilagyi A, Shrier I. Systematic review: the use of somatostatin or octreotide in refractory<br />
diarrhoea. Aliment Pharmacol Ther. 2001;15(12):1889-97.<br />
255. Ripamonti C, Mercadante S. Pathophysiology and management of malignant bowel obstruction.<br />
In: Doyle D, Hanks G, Chreney N, Calman K, editors. Third ed. Oxford: Oxford University<br />
Press; 2004. p. 496-507.<br />
256. Ripamonti C, Twycross R, Baines M, Bozzetti F, Capri S, De Conno F, et al. Clinical-practice<br />
recommendations for the management of bowel obstruction in patients with end-stage<br />
cancer. Supportive Care in Cancer. 2001;9(4):223-33.<br />
257. Watt AMB, Faragher IGF, Griffin TTP, Rieger NAM, Maddern GJP. Self-expanding Metallic<br />
Stents for Relieving Malignant Colorectal Obstruction: A Systematic Review. [Review].<br />
Annals of Surgery. 2007;246(1):24-30.<br />
GUÍA DE PRÁCTICA CLÍNICA SOBRE CUIDADOS PALIATIVOS 301